Credit Suisse’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	$965K	Hold	19,204	–	–	﹤0.01%	2288
2023 Q4	$1.16M	Buy	19,204 +5,067	+36%	+$306K	﹤0.01%	2239
2023 Q3	$806K	Buy	+14,137	New	+$806K	﹤0.01%	2414
2022 Q1	–	Sell	-371,849	Closed	-$3.68M	–	3587
2021 Q4	$3.68M	Buy	+371,849	New	+$3.68M	﹤0.01%	1727